PepGen (PEPG) Common Equity (2021 - 2026)
PepGen's Common Equity was $119.53 million in Q2 2026, up 68.0% from $71.16 million a year earlier but down 10.8% from the prior quarter.
Powered by 
Analysis
PepGen (PEPG) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at PepGen came in at $147.44 million, up 24.3% from FY2024.
- In earlier years, Common Equity was $118.62 million in FY2024 (+9.4%), $108.42 million in FY2023 (-39.6%), $179.63 million in FY2022 and -$32.08 million in FY2021.
- Quarterly Common Equity has moved between -$49.59 million (Q1 2022) and $210.22 million (Q2 2022) over five years.
- Compared with a year earlier, Common Equity has increased for four straight quarters, with growth averaging 9.1% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q2 2026 (growth of 68.0%); the worst was Q2 2025 (a decline of 54.1%).
- Per Business Quant data, PEPG's Common Equity in the three quarters before Q2 2026 was $133.98 million (Q1 2026), $147.44 million (Q4 2025) and $163.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | PepGen | 179.38 Mn | 179.38 Mn | - | 119.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 119.53 Mn |
| Mar 31, 2026 | 133.98 Mn |
| Dec 31, 2025 | 147.44 Mn |
| Sep 30, 2025 | 163.14 Mn |
| Jun 30, 2025 | 71.16 Mn |
| Mar 31, 2025 | 91.81 Mn |
| Dec 31, 2024 | 118.62 Mn |
| Sep 30, 2024 | 137.46 Mn |
| Jun 30, 2024 | 155.04 Mn |
| Mar 31, 2024 | 179.00 Mn |
| Dec 31, 2023 | 108.42 Mn |
| Sep 30, 2023 | 125.87 Mn |
| Jun 30, 2023 | 147.28 Mn |
| Mar 31, 2023 | 164.84 Mn |
| Dec 31, 2022 | 179.63 Mn |
| Sep 30, 2022 | 192.94 Mn |
| Jun 30, 2022 | 210.22 Mn |
| Mar 31, 2022 | -49.59 Mn |
| Dec 31, 2021 | -32.08 Mn |
| Sep 30, 2021 | -25.61 Mn |
API Access
PepGen Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PEPG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PEPG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PEPG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();